More broadly, under stress- and depression-related paradigms, EE reprogramed microglia toward anti-inflammatory phenotypes (15) and restrained NF-κB signaling, reducing NLRP3 priming (91, 93). The gene discussed is NLRP3; the disease is depressive symptom measurement.